Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Oral Health ; 24(1): 756, 2024 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-38951854

RESUMO

OBJECTIVE: Oral lichen planus carries a risk for malignancy. The pathogenesis of the disease is mediated by various inflammatory mediators. Several mediators could be responsible for the oncogenic behavior in certain cases. Hypoxia-inducible factor-1a (HIF-1), and its possible correlation to Galactin-3 (Gal-3) and matrix metalloproteinase-9 (MMP-9) over expression represents an important indicator for malignant transformation. The investigation of these factors may present evidence-based information on malignant transformation of the disease. SUBJECTS AND METHODS: The study investigated the expression of HIF-1, Gla-3 and MMP-9 in tissue samples of OLP compared to control subjects of un-inflamed gingival overgrowth. 20 biospecimen were allocated in each group. RESULTS: Immunohistochemical findings of OLP showed immunoreactivity for Galectin 3, HIF1a and MMP-9 by most of the epithelial cells. There was a positive correlation between HIF1α and MMP-9, r = 0.9301 (P-value < 0.00001). A positive correlation was detected between Galectin 3 and MMP-9, r = 0.7292 (P-value = 0.000264) between Galectin 3 and HIF1α, r = 0.5893 (P-value = 0.006252). CONCLUSION: These findings confirm the hypothesis that the adaptive pathways to hypoxia as Gal 3 and MMP-9 expressions and their HIF-1 may play a crucial role in carcinogenesis of OLP.


Assuntos
Galectina 3 , Subunidade alfa do Fator 1 Induzível por Hipóxia , Líquen Plano Bucal , Metaloproteinase 9 da Matriz , Humanos , Metaloproteinase 9 da Matriz/metabolismo , Líquen Plano Bucal/metabolismo , Líquen Plano Bucal/patologia , Galectina 3/metabolismo , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Feminino , Masculino , Pessoa de Meia-Idade , Galectinas/metabolismo , Adulto , Transformação Celular Neoplásica , Células Epiteliais/metabolismo , Estudos de Casos e Controles , Imuno-Histoquímica , Proteínas Sanguíneas
2.
BMC Oral Health ; 24(1): 763, 2024 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-38965550

RESUMO

BACKGROUND: There is insufficient clinical and microbiological evidence to support the use of diode laser and air-polishing with erythritol as supplements to scaling and root planning(SRP). The aim of the current study is to evaluate the clinical and microbiologic efficacy of erythritol subgingival air polishing and diode laser in treatment of periodontitis. METHODS: The study encompassed twenty-four individuals seeking periodontal therapy and diagnosed with stage I and stage II periodontitis. Eight patients simply underwent SRP. Eight more patients had SRP followed by erythritol subgingival air polishing, and eight patients had SRP followed by diode laser application. At baseline and six weeks, clinical periodontal parameters were measured, including Plaque Index (PI), Gingival Index (GI), periodontal Probing Depth (PPD), and Clinical Attachment Level (CAL). The bacterial count of Aggregatibacter actinomycetemcomitans(A.A), Porphyromonas gingivalis (P.G) was evaluated at different points of time. RESULTS: The microbiological assessment revealed significant differences in the count of A.A. between the laser and erythritol groups immediately after treatment, indicating a potential impact on microbial levels. However, the microbial levels showed fluctuations over the subsequent weeks, without statistically significant differences. Plaque indices significantly decreased post-treatment in all groups, with no significant inter-group differences. Gingival indices decreased, and the laser group showed lower values than erythritol and control groups. PPD and CAL decreased significantly across all groups, with the laser group exhibiting the lowest values. CONCLUSION: The supplementary use of diode laser and erythritol air polishing, alongside SRP, represents an expedited periodontal treatment modality. This approach leads to a reduction in bacteria and improvement in periodontal health. TRIAL REGISTRATION: This clinical trial was registered on Clinical Trials.gov (Registration ID: NCT06209554) and released on 08/01/2024.


Assuntos
Aggregatibacter actinomycetemcomitans , Carga Bacteriana , Índice de Placa Dentária , Raspagem Dentária , Eritritol , Lasers Semicondutores , Índice Periodontal , Porphyromonas gingivalis , Aplainamento Radicular , Humanos , Eritritol/uso terapêutico , Feminino , Masculino , Porphyromonas gingivalis/isolamento & purificação , Porphyromonas gingivalis/efeitos dos fármacos , Adulto , Raspagem Dentária/métodos , Lasers Semicondutores/uso terapêutico , Carga Bacteriana/efeitos dos fármacos , Pessoa de Meia-Idade , Aggregatibacter actinomycetemcomitans/isolamento & purificação , Aggregatibacter actinomycetemcomitans/efeitos dos fármacos , Aplainamento Radicular/métodos , Resultado do Tratamento , Bolsa Periodontal/terapia , Bolsa Periodontal/microbiologia , Perda da Inserção Periodontal/terapia , Perda da Inserção Periodontal/microbiologia , Periodontite/microbiologia , Periodontite/terapia , Periodontite/tratamento farmacológico , Seguimentos , Abrasão Dental por Ar/métodos
3.
Cureus ; 15(3): e36559, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37102010

RESUMO

Background Low-level laser treatment (LLLT) was thought to increase bone quality during osseointegration when combined with dental implants. However, there is no sufficient information on its impact on dental implants in diabetics. Osteoprotegerin (OPG) has been described as a marker for bone turnover to determine implant prognosis. The current research aims to evaluate the effect of low-level laser therapy (LLLT) on bone density (BD) and osteoprotegerin levels in peri-implant crevicular fluid (PICF) in type II diabetic patients. Methods This study comprised 40 individuals with type II diabetes mellitus (T2DM). Implants were randomly placed in 20 non-lasered T2DM patients (control) and 20 lasered T2DM patients (LLLT group). At the follow-up stages, BD and OPG levels in the PICF were evaluated in both groups. Results Significant variations were shown among control and LLLT groups concerning OPG level and BD (p≤0.001). OPG was significantly decreasing with follow-up points (p≤0.001). There was a significant decrease in OPG with time in both groups with a higher decrease in the control group. Conclusion LLLT is promising in controlled T2DM patients due to its outstanding influence on BD and estimated crevicular levels of OPG. Regarding its clinical significance, LLLT significantly improved bone quality during osseointegration on dental implants in T2DM. LLLT is considered potentially important for T2DM patients during implant placement. Trial registration The study was registered on ClinicalTrial.gov under registration number NCT05279911 (registration date: March 15, 2022) (https://clinicaltrials.gov/ct2/show/NCT05279911).

4.
Int Dent J ; 73(4): 524-532, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36543730

RESUMO

PURPOSE: This study was designed to investigate the effect of intramarrow penetration (IMP) and 1% melatonin (MLN) gel on the remodelling process of autogenous bone graft (ABG) in an induced 1-osseous wall defect model. METHODS: Sixty-four intrabony induced mandibular defects were created on the distal side of premolars-P1, P2, P3, and P4 (on each side)-in 8 beagle dogs. A ligature-induced periodontitis was initiated in each defect. Defects were then divided into 4 equal groups. Group I was treated with open-flap debridement (OFD) alone, group II was treated with OFD/ABG, group III was treated with OFD/IMP/ABG, and group IV was treated with OFD/ABG/IMP/1% MLN gel. The study parameters were bone fill, histologic analysis, and immunohistochemical evaluation of endothelial nitric oxide synthase (eNOS) expression at 2-week (2W) and 8-week (8W) time intervals. RESULTS: At 8W, significant differences were revealed amongst all groups regarding the amount of bone fill and eNOS expressions (P < .001). Bone fill percentages were 55.5%, 22.3%, 16.8%, and 0% in groups IV, III, II, and I, respectively. eNOS expressions were 1.68 ± 0.06, 8.43 ± 0.04, 16.80 ± 0.17, and 1.97 ± 0.07 in groups IV, III, II, and I, respectively. The favourable results were in line with group IV. CONCLUSIONS: According to these preliminary results, defects treated by ABG augmented with IMP and 1% MLN gel revealed a greater amount of bone fill and reduced eNOS expression. This combination is therefore highly suggested as an adjunct to ABG.


Assuntos
Perda do Osso Alveolar , Melatonina , Cães , Humanos , Animais , Perda do Osso Alveolar/cirurgia , Melatonina/farmacologia , Melatonina/uso terapêutico , Regeneração Tecidual Guiada Periodontal , Resultado do Tratamento
5.
J Int Acad Periodontol ; 21(2): 63-73, 2019 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-31522153

RESUMO

BACKGROUND: The combined orthodontic regenerative therapy approach can greatly enhance periodontal conditions and dentofacial aesthetics in many situations. The purpose of this study was to evaluate the effectiveness of 940nm low-level diode laser biostimulation in enhancement of intrabony wound healing with combined orthodontic/regenerative therapy in chronic periodontitis subjects suffering from malocclusion. METHODS: Fifteen chronic periodontitis adult patients with at least two intrabony defects and requiring orthodontic treatment for abnormalities in occlusion were included. A total of 30 defects were divided into two groups and treated in a split mouth design. The defects were treated with combined orthodontic regenerative therapy with laser irradiation (Group I: test group) or with combined orthodontic regenerative therapy alone (Group II: control group). The following hard and soft tissue measurements were recorded at baseline (prior to surgery) and after six and nine months postoperatively: probing depth (PD), clinical attachment level (CAL) by periodontal calibrated probe and bone density (BD) using the DBS-Win software. RESULTS: Probing depth reduction was 64.57%±9.37 and 64.95%±10.07 with no statistically significant difference between Group I and Group II. Percent change in clinical attachment level gain were 59.77%±12.107and 38.83%±7.56 in Group I and II respectively, with a statistically signifi cant difference (P-value =0.005considered signifi cant). Moreover, defects treated with combined orthodontic regenerative therapy with laser irradiation showed signifi cant preservation of bone density with a percent decrease of 4.14%±3.17 at the end of the study period. CONCLUSION: Improvements in clinical and radiographic parameters were observed following the adjunctive use of low-level diode laser therapy and orthodontic regenerative therapy for the management of intrabony defects in chronic periodontitis patients.


Assuntos
Perda do Osso Alveolar , Terapia com Luz de Baixa Intensidade , Adulto , Estética Dentária , Seguimentos , Regeneração Tecidual Guiada Periodontal , Humanos , Perda da Inserção Periodontal , Bolsa Periodontal , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...